ACAD
34.45
-0.48
-1.37%
AEMD
3.75
+0.1
+2.74%
APRI
2.29
+0.03
+1.33%
ARNA
1.45
+0.02
+1.40%
ATEC
2.07
-0.61
-22.76%
CNAT
4.59
+0.19
+4.32%
CRXM
0.2
-0.01
-4.76%
CYTX
1.64
+0.03
+1.86%
DXCM
76.08
-0.82
-1.07%
GNMK
13.14
+0.12
+0.92%
HALO
13.46
-0.03
-0.22%
ILMN
167.69
-0.1
-0.06%
INNV
0.11
0.00
+1.63%
INO
5.95
+0.03
+0.51%
ISCO
1.65
-0.1
-5.71%
ISIS
57.56
0.00
0.00%
LGND
103.79
-0.28
-0.27%
LPTN
2.93
0.00
0.00%
MBVX
2.51
+0.06
+2.45%
MEIP
1.57
+0.03
+1.95%
MNOV
5.81
+0.01
+0.17%
MRTX
5.1
-0.05
-0.97%
MSTX
0.107
+0.01
+9.744%
NBIX
41.5
-0.22
-0.53%
NUVA
74.295
-0.255
-0.342%
ONCS
1.25
-0.01
-0.79%
ONVO
3.01
0.00
0.00%
OREX
4
0.00
0.00%
OTIC
13.1
-0.05
-0.38%
QDEL
21.675
+0.365
+1.713%
RCPT
231.96
0.00
0.00%
RGLS
1.25
0.00
0.00%
RMD
71.31
+0.02
+0.03%
SPHS
2.58
+0.03
+1.18%
SRNE
4.2
+0.05
+1.20%
TROV
1.15
+0.15
+15.00%
VICL
2.13
-0.05
-2.29%
VOLC
18
0.00
0.00%
ZGNX
10.4
+0.05
+0.48%
ACAD
34.45
-0.48
-1.37%
AEMD
3.75
+0.1
+2.74%
APRI
2.29
+0.03
+1.33%
ARNA
1.45
+0.02
+1.40%
ATEC
2.07
-0.61
-22.76%
CNAT
4.59
+0.19
+4.32%
CRXM
0.2
-0.01
-4.76%
CYTX
1.64
+0.03
+1.86%
DXCM
76.08
-0.82
-1.07%
GNMK
13.14
+0.12
+0.92%
HALO
13.46
-0.03
-0.22%
ILMN
167.69
-0.1
-0.06%
INNV
0.11
0.00
+1.63%
INO
5.95
+0.03
+0.51%
ISCO
1.65
-0.1
-5.71%
ISIS
57.56
0.00
0.00%
LGND
103.79
-0.28
-0.27%
LPTN
2.93
0.00
0.00%
MBVX
2.51
+0.06
+2.45%
MEIP
1.57
+0.03
+1.95%
MNOV
5.81
+0.01
+0.17%
MRTX
5.1
-0.05
-0.97%
MSTX
0.107
+0.01
+9.744%
NBIX
41.5
-0.22
-0.53%
NUVA
74.295
-0.255
-0.342%
ONCS
1.25
-0.01
-0.79%
ONVO
3.01
0.00
0.00%
OREX
4
0.00
0.00%
OTIC
13.1
-0.05
-0.38%
QDEL
21.675
+0.365
+1.713%
RCPT
231.96
0.00
0.00%
RGLS
1.25
0.00
0.00%
RMD
71.31
+0.02
+0.03%
SPHS
2.58
+0.03
+1.18%
SRNE
4.2
+0.05
+1.20%
TROV
1.15
+0.15
+15.00%
VICL
2.13
-0.05
-2.29%
VOLC
18
0.00
0.00%
ZGNX
10.4
+0.05
+0.48%
Home » Archive by Category

Xconomy

The Power of the Cloud for Life Science R&D

October 19, 2016 – 5:43 am

“In the new world, it is not the big fish which eats the small fish, it’s the fast fish which eats the slow fish…” — Klaus Schwab, Founder/Executive Chairman, World…

[[Click headline to continue reading.]]

After “Hubris” and Its HCV Collapse, Can Vertex Avoid Same Mistakes?

October 18, 2016 – 3:50 am

Five years ago, in November 2011, a company from Princeton, NJ, called Pharmasset shared news that would have an impact on millions of people around the world with hepatitis C. Its experimental drug…

[[Click headline to continue reading.]]

Ex-Celgene Dealmaker Tom Daniel Charts a New Course Advising Biotechs

October 17, 2016 – 3:50 am

For close to a decade, Tom Daniel and George Golumbeski comprised perhaps one of the best-known dealmaking duos in biopharma, striking a slew of alliances that established Summit, NJ-based Celgene as…

[[Click headline to continue reading.]]

Bio Roundup: Bristol & Illumina Blues, Sickle Cell News & More

October 14, 2016 – 6:00 am

On Aug. 4, shares of Bristol-Myers Squibb closed at $75.32. Today, shares are worth just over $50. That means in three months, Bristol has lost a third of its value, equivalent to about $40 billion…

[[Click headline to continue reading.]]

Life Science Leaders Who Feel the Right Kind of Fear

October 12, 2016 – 3:00 am

In the world of betting on the future, life sciences find themselves in a storm, with huge opportunities, like CRISPR gene editing, and immense obstacles, such as soaring drug prices, that call for…

[[Click headline to continue reading.]]

How Doctors Think About Drug Prices

October 11, 2016 – 5:30 am

There are a lot of factors involved in drug pricing that don’t enter my head when I’m seeing a patient. The three letters “PBM,” for example (pharmacy benefit manager), have never crossed my mind…

[[Click headline to continue reading.]]

Checkpoints In Lung Cancer, and Other Oncology News From Europe

October 11, 2016 – 12:00 am

The European Society for Medical Oncology’s annual conference wraps up in Copenhagen today. We’ve seen updates on heavyweight immunotherapy programs, potential options for patients with…

[[Click headline to continue reading.]]

Bio Roundup: Theranos Cuts, Alnylam Stops, Nobel Eats Its Own & More

October 7, 2016 – 3:30 am

[Updated, 11:50 a.m. ET, see below] With the Caribbean and now the southeast U.S. coast bearing the brunt of Hurricane Matthew, we send our thoughts and more to those who have more pressing matters…

[[Click headline to continue reading.]]

With New Program, DARPA To Encourage Safety “Brakes” For Gene Editing

October 5, 2016 – 11:18 am

[Updated 10/6/16, 12:17 p.m. See below.] Drugs that use molecular scissors to snip out or replace defective genes. Altered mosquitoes meant to sabotage entire disease-carrying populations. Both are…

[[Click headline to continue reading.]]

Organovo to Test “Patches” for Patients Awaiting Liver Transplants

October 5, 2016 – 8:33 am

San Diego-based Organovo (NASDAQ: ONVO) said today it plans to use its 3D bio-printing technology to produce living human liver tissue “patches” that can be transplanted in patients with fatal liver…

[[Click headline to continue reading.]]